NASDAQ:COCP

Cocrystal Pharma Stock News

etoro logo Buy COCP
*Your capital is at risk
$1.06
+0.0100 (+0.95%)
At Close: Jun 03, 2026

Mesh Expands Presence to Austin

02:37pm, Tuesday, 02'nd Jun 2020
One of your neighbors posted in Neighbor News. Click through to read what they have to say. (The views expressed in this post are the author’s own.)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F
Gilead Sciences has recently advanced its work with Filgotinib while improving its oncology portfolio increasing the strength of its overall portfolio. The comp
The company has been able to rapidly ramp up testing for COVID-19. Its revenue figures are down as sales of its other products have been affected by confinement
David Einhorn's 13F stock portfolio value decreased from $1.35B to $702M this quarter. Greenlight added Change Healthcare and increased CNX Resources while drop
Last Friday, the primary and secondary students of Foundry College came together to create a range of artwork and posters in response to a shout out by Wokingham borough council, who asked pupils to s
It's finally time to write about my favorite pharma stock in the corona-discount model. Bristol-Myers Squibb has gone from being a rather insignificant holding
Here's what's happened in the courts this week

Indonesia ikut "solidarity trial" vaksin COVID-19

02:31am, Saturday, 16'th May 2020
Indonesia telah mendaftar untuk mengikuti program uji coba global (solidarity trial) untuk vaksin COVID-19 yang dikoordinasi oleh Organisasi Kesehatan Dunia ...
In 2016, Gary Wilcox was appointed CEO of Cocrystal Pharma, Inc. (NASDAQ:COCP). This report will, first, examine the...
Cocrystal Pharma, Inc (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, today announced its
Domestic players will be free to price it; Dutch firm Mylan also to make the drug in India; no royalty for Gilead as yet
AHF Demands Gilead Price Remdesivir at $1.00 per Dose
Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, today provided an u
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE